C

Compass Therapeutics
D

CMPX

1.83000
USD
0.08
(4.57%)
Market Closed
Volume
50,668
EPS
0
Div Yield
0
P/E
-5
Market Cap
251,788,183
OverviewSignalsIdeasNews
Related Instruments
    C
    CMP
    -0.860
    (-6.45%)
    12.470 USD
    C
    CMPR
    3.990
    (4.36%)
    95.470 USD
    C
    CMPS
    -0.76000
    (-9.96%)
    6.87000 USD
News

Title: Compass Therapeutics

Sector: Healthcare
Industry: Biotechnology
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.